Profil
Chen Zong is currently President at Harbour BioMed (Shanghai) Co., Ltd. and President at HBM Holdings Ltd., both positions starting in 2026.
Formerly, Dr. Zong was President & Chief Operating Officer at Seven & Eight Biopharmaceuticals, Inc. Education includes a doctorate from The Rockefeller University and an MBA from The Wharton School of the University of Pennsylvania.
Aktiva positioner av Adam Zong
| Företag | Position | Start |
|---|---|---|
| HBM HOLDINGS LIMITED | President | 2026-04-16 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | President | 2026-04-16 |
Tidigare kända positioner av Adam Zong
| Företag | Position | Slut |
|---|---|---|
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | President | - |
Adam Zongs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | Health Technology |
















